Appetite, glucose regulation, and the way cells handle energy.
Tirzepatide
10 mg / 20 mg / 30 mgTirza
A dual GIP and GLP-1 receptor agonist studied for glucose regulation, appetite signaling, and body-weight outcomes.
What researchers study
Acts on GIP and GLP-1 receptors, pathways involved in insulin release and appetite signaling. Researchers examine glucose regulation and changes in body weight.
Evidence & limitations
Human clinical trials and receptor studies. Findings concern the studied formulations and populations; they do not validate a research vial for personal use.
Retatrutide
10 mg / 20 mg / 30 mgReta
An investigational GIP, GLP-1, and glucagon receptor agonist studied for metabolic signaling, glucose regulation, and body-weight outcomes.
What researchers study
Acts on GIP, GLP-1, and glucagon receptors. Researchers study how this combination affects metabolic signaling and body-weight outcomes.
Evidence & limitations
Human clinical research, including a randomized phase 2 trial. A third receptor is a mechanistic difference, not proof that it is better or safer than tirzepatide.
Cagrilintide
5 mg / 10 mgAn investigational amylin analogue studied for satiety signaling, food intake, and body-weight outcomes.
What researchers study
Mimics amylin, a hormone involved in feeling full. Researchers examine appetite-related signaling, food intake, and body-weight changes.
Evidence & limitations
Human clinical research, including a randomized phase 2 trial. Results from an individual trial do not establish benefits or safety for a different product or a combination of compounds.
MOTS-C
10 mgA mitochondrial-derived peptide investigated in laboratory and animal models for cellular energy sensing, glucose metabolism, and insulin sensitivity.
What researchers study
A peptide encoded by mitochondrial DNA. Laboratory studies examine cellular energy sensing, glucose use, and insulin sensitivity.
Evidence & limitations
The cited evidence comes from cell experiments and animal models. These findings cannot be treated as established benefits in people.